Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Recurrence and SULT1A1[original query] |
|---|
| Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. Journal of cancer research and clinical oncology 2004 Feb 130 (2): 99-106. Tsukino Hiromasa, Kuroda Yoshiki, Nakao Hiroyuki, Imai Hirohisa, Inatomi Hisato, Osada Yukio, Katoh Takahi |
| Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients. Breast cancer research : BCR 2005 7 (3): R284-90. Wegman Pia, Vainikka Linda, Stål Olle, Nordenskjöld Bo, Skoog Lambert, Rutqvist Lars-Erik, Wingren St |
| Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast cancer research and treatment 2005 Jun 91 (3): 249-58. Nowell Susan A, Ahn Jiyoung, Rae James M, Scheys Joshua O, Trovato Andrew, Sweeney Carol, MacLeod Stewart L, Kadlubar Fred F, Ambrosone Christine |
| Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 May 14 (5): 1090-5. Choi Ji-Yeob, Lee Kyoung-Mu, Park Sue Kyung, Noh Dong-Young, Ahn Sei-Hyun, Chung Hye-Won, Han Wonshik, Kim Jeong Soo, Shin Sang Goo, Jang In-Jin, Yoo Keun-Young, Hirvonen Ari, Kang Daeh |
| Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer. Breast cancer research : BCR 2007 9 (1): R7. Wegman Pia, Elingarami Sauli, Carstensen John, Stål Olle, Nordenskjöld Bo, Wingren St |
| Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms. The Journal of urology 2010 Aug 184 (2): 506-11. Morote Juan, Del Amo Jokin, Borque Angel, Ars Elisabet, Hernández Carlos, Herranz Felipe, Arruza Antonio, Llarena Roberto, Planas Jacques, Viso María J, Palou Joan, Raventós Carles X, Tejedor Diego, Artieda Marta, Simón Laureano, Martínez Antonio, Rioja Luis |
| Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer. Journal of cancer research and clinical oncology 2010 Dec 136 (12): 1813-9. Knechtel Gudrun, Hofmann Günter, Gerger Armin, Renner Wilfried, Langsenlehner Tanja, Szkandera Joanna, Wolf Gerald, Samonigg Hellmut, Krippl Peter, Langsenlehner U |
| SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen. Pharmacogenomics 2011 Nov 12 (11): 1535-43. Moyer Ann M, Suman Vera J, Weinshilboum Richard M, Avula Rajeswari, Black John L, Safgren Stephanie L, Kuffel Mary J, Ames Matthew M, Ingle James N, Goetz Matthew |
| Genetic predisposition to early recurrence in clinically localized prostate cancer. BJU international 2013 Apr 111 (4): 549-58. Borque Ángel, del Amo Jokin, Esteban Luis M, Ars Elisabet, Hernández Carlos, Planas Jacques, Arruza Antonio, Llarena Roberto, Palou Joan, Herranz Felipe, Raventós Carles X, Tejedor Diego, Artieda Marta, Simon Laureano, Martínez Antonio, Carceller Elena, Suárez Miguel, Allué Marta, Sanz Gerardo, Morote Ju |
| Relationship between genotypes Sult1a2 and Cyp2d6 and tamoxifen metabolism in breast cancer patients. PloS one 2013 8 (7): e70183. Fernández-Santander Ana, Gaibar María, Novillo Apolonia, Romero-Lorca Alicia, Rubio Margarita, Chicharro Luis Miguel, Tejerina Armando, Bandrés Fernan |
| Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer. International journal of environmental research and public health 2018 Jul 15 (8): . Carta Angela, Pavanello Sofia, Mastrangelo Giuseppe, Fedeli Ugo, Arici Cecilia, Porru Stefa |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: